Get Permission Nigudgi, Hajare, Biradar, and Anandkumar H: Evaluation of cell surface hydrophobicity and biofilm formation as pathogenic determinants among ESBL producing uropathogenic Escherichia coli


Introduction

The pathogenic Escherichia coli strains are common cause of extra intestinal infections such as urinary tract infection, neonatal meningitis, as well as bacteraemia.1, 2 The strains that cause extra-intestinal infections possess virulence factors (VF) that enhance the ability to cause systemic infection.3, 4, 5 In Escherichia coli isolates virulence results from the cumulative impact of one or several special properties, or VFs, which distinguish potential pathogens from harmless intestinal strains.

At some point of life, at least 12% of men and 10-20% of women experience an acute symptomatic UTI6,7 and an even greater number develop asymptomatic bacteriuria (ABU).

A vital step in early stages of infection by many bacterial pathogens is the initial adherence to the mucosal surfaces of respiratory, gastrointestinal or urinary tract epithelium and in some instances colonization alone may be sufficient to cause disease8. The hydrophobic interaction plays a role in the adherence of microorganisms to a wide variety of surfaces.4, 6, 7, 8 The fimbrial adhesions found in pathogenic E.coli are predominantly composed of hydrophobic aminoacids, these increase the surface hydrophobicity and reduce the cell surface charge.9, 10, 11, 12 Bacterial cell adhesins can be ranked on the basis of their hydrophobicity with recognized pathogenic E. coli showing a greater surface hydrophobicity than non pathogens.9, 12 The hydrophobicity of the microbial surface plays a critical role in the adherence of bacteria to the wide variety of surfaces.10, 13 And it is also a significant determinant of adhesion and biofilm formation on polystyrene surfaces.11, 14 The ability of biofilm formation can increase survival of microorganism, as cells growing in biofilm are highly resistant to the components of the human immune system and many antimicrobial agents.12, 15, 16, 17

Also, the infection caused by ESBL- producers is associated with adverse outcomes and may be related to increased virulence of the strains.15, 18, 19 Some studies have reported an association between ESBL- production and the higher expression pathogenicity factors.8, 20

Such infections are extremely difficult to eradicate and the fact that cell surface hydrophobicity (CSH) and biofilm formation play a significant role in a wide range of microbial infections.

Hence, this study was performed to evaluate the CSH and Biofilm formation as two cell surface determinants involved in pathogenecity of among ESBL- and non-ESBL- producing Escherichia coli isolated from patients with urinary tract infection.

Materials and Methods

The prospective study was conducted in the Department of Microbiology, Shyam Shah Medical College, Rewa, Madhya Pradesh, India. The study material and data collections were carried out with the approval from institutional ethical committee and informed consent were taken from all the subjects willing to participate.

The Clean -catch mid-stream urine samples collected in (uricol, Hi-Media) sterile disposable container were immediately transported to the laboratory within one hour. The semi quantitative calibrated loop technique was employed to culture urine on blood agar and Mac Conkey agar. The inoculated plates were incubated over night at 37oC. The significant growth of bacteria on culture media (colony count ≥105 CFU/ml) was identified and sensitivity testing was done by standard procedures.21, 22 Throughout the study, standard strains including Escherichia coli ATCC 25922 and Klabsiella pneumonia ATCC 700603 were used as the controls.

Detection of extended spectrum β- lactamases

The strains which showed resistance to at least one of the indicator cephalosporins were confirmed with E-strip test (AB Biomeurix Solna, Sweden). 22, 23

The E test ESBL strip carries two gradients; on the one end, Ceftazidime (0.5 to 32 ug/ml) and on the opposite end, Ceftazidime (0.125 to 8 g/ml) plus Clavulanic acid (4 ug/ml). Briefly, after overnight growth on brain heart infusion agar, the organisms were suspended in saline to turbidity equal to that of a 0.5 McFarland turbidity standard. This suspension was then used to inoculate Mueller Hinton agar, the E test strips were placed on the plates and incubated overnight in air at 37ºC. The MICs on both ends of the strip were interpreted as the point of intersection of the inhibition eclipse with the E-test strip edge.6, 19, 24, 25

Salt aggregation test for detection of Cell Surface Hydrophobicity (CSH)

Bacteria were tested for their hydrophobic property by using different molar concentrations of ammonium sulphate. Those which aggregated with salt particles and formed clumps were considered hydrophobic. The colonies of E.coli were inoculated into 1 ml of PBS pH 6.8 and turbidity were matched with Mc Farland tubes 6 and 7 to get a colony count of 5x106 colonies/ml. Different molar concentrations of ammonium sulphate were prepared. Forty microliter of 0.2 M PBS pH6.8 was taken in first column of VDRL slide. And 40 ul of 1M, 1.4 M, and 2M concentration of ammonium sulphate were taken in each well of other columns of VDRL slide. Forty microliter of E.coli suspension was added to each of these wells. The clumps formed in different molar concentrations were observed under inverted microscope at 20X magnification.26 The results were recorded on three scales namely, weak 0.1M, 0.4 M, Moderate 1.0M,1.4 M & Strong CSH ≥ 2.0 M.

Detection of Biofilm formation by Tissue Culture Plate (TCP) method

A volume of 200 ul of Escherichia coli was inoculated in microtitre plate and incubated for 18 hours at 37oC. The wells were washed four times with PBS (pH 7.2) to remove free floating ‘planktonic’ bacteria. Biofilms formed by adherent sessile organisms were fixed with 200 µl 99% methanol in each well and stained with 0.1% (w/v) Crystal violet for five minutes. Excess stain was rinsed off by placing the plate under running tap water. The plates were air dried and dye attached to well was dissolved in 200 µl of 33% glacial acetic acid. Optical Density (OD) of each well was determined by using ELISA Reader (Biotek ELX 800-MS) at 490 nm (OD490 nm). These OD values were considered as an index of bacteria adhering to surface and forming biofilm.23, 24, 27, 28 Experiment was performed in triplicate, the data was then averaged. The bacterial adherence was recorded as weak/non (OD <0.120), Moderate (OD 0.12-0.24) and strong (OD >0.24)

Statistical analysis

The results were analyzed with descriptive statistics wherever appropriate. Fisher’s exact test was used to evaluate the statistical significance of differences in the result. A p-value of <0.05 was considered statistically significant. Statistical analysis was performed using SPSS v 16.0 software.

Results

A total of 100 urinary E.coli isolates included in the study were screened for ESBL production by using three indicator cephalosporins, ceftazidime (30 µ g), cefotaxime (30 µg) and cefpodoxime (30 µg). The zone diameter of < 22 mm for ceftazidime, < 27 mm for cefotaxime and <17 mm for cefpodoxime was recorded as resistant. The strains which showed resistance to at least one of these cephalosporins were further confirmed for the production of ESB Lenzyme by E-strip method. The ratio of Ceftazidime / Ceftazidime- Clavulanate MIC equal to or greater than 8 were considered positive for ESBL enzyme production.

All the100 urinary Escherichia coli strains were tested for the presence of cell surface hydrophobicity and the ability of biofilm production of which 50 strains from confirmed ESBL positives strains and 50 strains from non-ESBL-producing group. Among 100 E.coli isolates 37 were cell surface hydrophobicity positive and 46 E.coli strains were biofilm producers

Out of 50 ESBL producing E.coli isolates, 29 (58%) strains were positive for cell surface hydrophobicity, of which 12 (24%) were strongly positive and16 (32%) were moderately positive. In 50 Non-ESBL E.coli strains, only 8 (16%) were positive for cell surface hydrophobicity as depicted in Table 1.

Table 1

Detection of cell surface hydrophobicity among ESBL and non- ESBL producing E.coli isolates

ESBL Production

Aggregation at different molar concentrations

Salt Aggregation

CSH Positive

2.0 M

1.4 M

1.0 M

0.4M

0.1 M

Positive

N=50

12

07

09

01

00

29

19 (38%)

Negative

N=50

03

02

03

00

00

08

05 (10%)

Total

N=100

15

09

12

01

00

37

24 (24%)

Among 10 E.coli strains tested for biofilm formation, 46 strains were biofilm producers, in which 34 (68%) strains were from ESBL producers and 12 (24%) strains were non-ESBL producers. A total of 54 E.coli strains were non/weak biofilm producers, of which ESBL producing E.coli contributed 16 (29.6%) isolates and non –ESBL producing E.coli, 38 (70.4%) isolates. Among 50 ESBL producing E.coli strains, 12 (24%) were strongly biofilm producers and 22 (44%) moderately biofilm producers. Comparatively, only 12 (24%) non-ESBL E.coli strains positive for biofilm production, of which 5 (10%) were strongly positive for biofilm production and 7 (14%) were moderately positive for biofilm production. In ESBL producing E.coli strains, the mean OD of biofilm formation was 0.194 ± 0.12 with a OD range of 0.072 to 0.312 and in non-ESBL strains of E.coli, the mean OD was 0.128 ±0.094 with the OD range of 0.034-0.224 as mentioned in Table 2.

Table 2

Detection of Biofilm formation among ESBL and non- ESBL producing E.coli isolates

ESBL Production

Biofilm formation

Biofilm Positive

Strong OD value

(>0.24)

Moderate OD value

(0.124-0.24)

Weak/non biofilm OD value (<0.12)

Positive

N=50

12

22

16

34 (68%)

Negative

N=50

05

07

38

12 (24%)

Total

N=100

17

29

54

46 (46%)

Among ESBL producing E.coli, 21 strains were having both CSH and biofilm producing virulence ability. However, among non-ESBL E.coli only 02 strains were having both the virulence factors.

Statistically significant difference was seen in the occurrence of cell surface hydrophobicity (p= 0.0019) as well as biofilm production (p<0.0001) between ESBL and non ESBL producing uropathogenic Escherichia coli isolates (Table 3).

Table 3

Occurrence of virulence factors among ESBL and non- ESBL producing E.coli isolates.

Virulence Factors in E.coli

ESBL Producing E.coli

Non-ESBL Producing E.coli

-Value

Cell surface hydrophobicity

19

05

0.0019

Biofilm formation

34

12

<0.0001

Discussion

In our study, the salt aggregation was recorded in 24 out of 100 strains as they have shown clumping in ≤ 1.4 M salt solution. Similarly, Raksha et al29 found that a total 58 (26.36%) among 220 cases and 9 (18%) strains among 50 controls were cell surface hydrophobic. In another study by Sharma et al,30 out of 152 E.coli strains tested for virulence factors, 42 strains (27.6%) were hydrophobic and observed 67 (44.0%) strains of E.coli with multiple virulence factors

A significant difference in the CSH (p=0.0019) of the ESBL producing Escherichia coli isolates was seen in comparison with non-ESBL producing isolates. This finding was in accordance with the study carried out by Sharma et al30 as they also showed significant association between multiple virulence factors and ESBL production in extra- intestinal Escherichia coli.

Among 50 ESBL positive isolates, 34 (68%) were positive for Biofilm formation, however only 12 (24%) strains of Escherichia coli among non-ESBL group showed Biofilm formation. Another study by Mathur et al31 recorded that 22 (14.4%) isolates were strong biofilm producers, 60 (39.4%) moderate and 70 (46%) non biofilm producers.

The first step in bacterial infection is adherence and colonization of the bacteria to the surface. CSH is an importance adherence and colonization factor. It’s a complex interaction between components of the surface of bacteria and surrounding environment. Pompilio et al32 found a positive correlation between CSH and Biofilm formation in Stenotrophomonas multophila. Lee et al33 showed a positive correlation between Biofilm formation and presence of ESBL bla PER-1 among the Acinetobacter baumannii. A correlation between ESBL type PER in Acinetobacter species and Pseudomonas aeruginosa with poor clinical outcome has been reported by Vahaboglu et al.34 In our region data is lacking regarding the presence of virulence factors in pathogenic organisms and their association with drug resistance like extended spectrum beta lactamases. The studies on more number of phenotypic virulence factors and their virulence gene is necessary to compare the pathogenecity of ESBL and non-ESBL producing isolates.

In this study we found that ESBL producing isolates had a higher ability to form biofilm in comparison with non ESBL producing isolates, Also ESBL producing isolates had a significantly higher CSH; both of them are among the important virulent factors associated with cell surface. It has been suggested that a number of chromosomal gene rearrangement occurs upon acquisition of the ESBLplasmid. It is possible that higher mortality and severity of infection caused by ESBL producing isolates is due to the expression of several virulence genes simultaneously, rather than gaining new virulence genes.20

There is hardly any report regarding CSH and biofilm formation in clinical isolates of E.coli producing and non-producing ESBLs. However, study on the gene expression is necessary to compare the pathogenicity of ESBL and non ESBL isolates. Due to highly emerged isolates producing different types of ESBL and the importance of ESBL producing E.coli, study on other virulence factors both genetically and phenotypically is recommended.

Source of Funding

None.

Conflict of Interest

The authors declare no conflict of interest.

References

1 

WE Stamm TM Hooton Management of urinary tract infection in adultsN Eng J Med1993329132834

2 

A Ronald The etiology of urinary tract infection: tradition and emerging pathogensAm J Med2002113Suppl.1A149

3 

JN Maslow TS Whittam CF Gilks RA Wilson ME Mulligan KS Adams Colon relationships among blood stream isolates of Escherichia coliInfect Immun1995637240917

4 

JR Johnson JJ Brown JN Maslow Clonal distribution of three alleles of the gal (α1-4) gal specific adhesion gene pap G among Escherichia coli strains from patients with bacteremiaJ Infect Dis1998177365161

5 

JR Johnson AL Stell Extended virulence genotype of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromiseJ Infect Dis2000181126172

6 

EH Beachey Bacterial adherence: adhesion-recceptor infections mediating the attachment of bacteria to mucosal surfaceJ Infect Dis1981143332545

7 

V Rodrigues HJ Busscher W Norde J Vries HC Mei Relation between macroscopic and microscopic adhesion of S.mitis strains to surfacesMicrobiology (Reading)2004150Pt 4101522

8 

M Rosenberg Bacterial adherence to polystyrene: a replica method of screening for bacterial hydrophocityAppl Envir Micro19814223757

9 

BA Lipsky Urinary tract infection in men. Epidemiiology, pathophysiology, diagnosis and treatmentAnn Intern Med1989110213850

10 

GW Jones The attachment of bacteria to the surfaces of animal cellsMicrobial interactions, receptors and recognition. Series BChapman and HallLondon199713976

11 

P Klemm primary structure of the CFA/1 fimbrial protein from human enterotoxigenic Escherichia coli strainsEur J Biochem1982124233948

12 

M Lindahl A Faris T Wadstrom S Hjerten A new test based on salting out the measure relative surface hydrophobicity of bacterial cellsBiochem Biophys Acta19816773–44716

13 

M Rosenberg Bacterial adherence to polystyrene: a replica method of screening for bacterial hydrophocityAppl Environ Microbiol1981423757

14 

A Pompilio R Piccolomini C Picciani D’ Antonio D Savini GDI Bonaventura Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas multophila: the role of cell surface hydrophobicity and motilityFEMS2008287417

15 

SY Lee S Kotapati JL Kuti CH Nightingale DP Nicolau Impact of extended spectrum beta lactamase producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort studyInfect Control Hosp Epidemiol200627122632

16 

M Matsukawa EP Greenberg Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm developmentJ Bacteriol200418614444956

17 

LG Leid CJ Willson ME Shirtliff DJ Hassett MR Parsek AK Jeffers The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN- {gamma}- mediated macrophage killingJ Immunol20051751175128

18 

MJ Schwaber S Navon-Venezia KS Kaye R Ben-Ami D Schwartz Y Carmeli Clinical and Economic impact of bacteremia with extended spectrum beta lactamase producing EnterobacteriaceaeAntimicrob Agents Chemother2006504125762

19 

MJ Schwaber Y Carmeli Mortality and delay in infective therapy associated with extended spectrum beta lactamase producing Enterobacteriaceae bacterimia: a systematic review and meta analysisJ Antimicrob Chemother200760591320

20 

H Sahly S Navon-Venezia L Roesler A Hay Y Carmeli R Podschun Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniaeAntimicrob Agents Chemother2008529302934

21 

JG Collee RS Miles B Watt JG Collee AG Fraser BP Marmion A Simmons Tests for the identification of bacteriaMackie and Mc Cartney Practical Medical Microbiology14th editionChurchill Livingstone IncLondon199613149

22 

Clinical and Laboratory Standard Institute. Performance Standards forantimicrobial Disc Susceptibility Tests. NCCLS Documents, M100 – SIS, 940 West Valley Road, Wayne, PA, 19087, USA, 2005

23 

S Srisangkaew M Vorachit The Optimum Agent for Screening and Confirmatory Tests for Extended- Spectrum beta-Lactamases in Escherichia coli and Klebsiella pneumoniae in Ramathibodi HospitalJ Infect Dis Antimicrob Agents20042115

24 

V Gupta An update on newer β- lactamasesIndian J Med Res200712641727

25 

MG Cormican SA Marshall RN Jones Detection of extended spectrum β-lactamase - producing strains by the E-test ESBL ScreenJ Clin Microbiol19963418804

26 

L Siegfried M Kmetova H Puzove M Molokacova J Filka Virulence- associated factors in Escherichia coli strains isolated from children with urinary tract infectionsJ Med Microbiol19944112732

27 

GD Christensen WA Simpson JA Younger LM Baddour FF Barrett DM Melton Adherence of coagulase negative Staphylococci to plastic tissue culture plates: a quantitative model for the adherence of Staphylococci to medical devicesJ Clin Microbiol1985229961006

28 

T Mathur S Singhal S Khan DJ Upadhyay T Fatma A Rattan Detection of biofilm formation among the clinical islolates of Staphylococci: an evaluation of three different screening methodsIndian J Med Microbiol200624259

29 

R Raksha H Srinivasa RS Macaden Occurrence and characterization of UPEC in urinary trcat infectionIndian J Med Microbiol20032121027

30 

S Sharma GK Bhat S Shenoy Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infectionsIndian J Med Microbiol20072536973

31 

T Mathur S Singhal S Khan D J Upadhyay T Fatma A Rattan Detection of biofilm formation among the clinical islolates of Staphylococci: an evaluation of three different screening methodsIndian J Med Microbiol2006242534

32 

A Pompilio R Piccolomini C Picciani D D’ Antonio V Savini GDI Bonaventura Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas multophila: the role of cell surface hydrophobicity and motilityFEMS Microbiol Lett20082871417

33 

HW Lee YM Koh J Kim JC Lee YC Lee SY Seol Capacity of multidrug -resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfacesClin Microbiol Infect20081414954

34 

H Vahaboglu F Coskunkan O Tansel R Ozturk N Sahin I Koksal Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strainsJ Med Microbiol20015076425



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 29-11-2021

Accepted : 29-11-2021


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2021.054


Article Metrics






Article Access statistics

Viewed: 2016

PDF Downloaded: 598



Medical Abbreviation List